EGF stimulates cyclooxygenase-2 expression through the STAT5 signaling pathway in human lung adenocarcinoma A549

Shouqiang Cao1, Yubo Yan, Xiangyu Zhang

  • 1Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, PR China.

Insights

Epidermal growth factor (EGF) stimulates cyclooxygenase-2 (COX-2) in lung cancer cells by activating STAT5. This study reveals STAT5

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) signaling pathways are crucial for tumor development.
  • Signal transducer and activator of transcription 5 (STAT5) is a key transcription factor in oncogenic signaling pathways, particularly in non-small cell lung cancer.
  • EGFR activation can lead to the activation of downstream pathways converging on transcription factors like STAT5.

Purpose of the Study:

  • To investigate whether epidermal growth factor (EGF) stimulates cyclooxygenase-2 (COX-2) expression in human lung adenocarcinoma A549 cells.
  • To identify the specific signaling pathways involved in EGF-mediated COX-2 expression, with a focus on STAT5.
  • To elucidate the role of STAT5 phosphorylation and activity in regulating COX-2 expression.

Main Methods:

  • Utilized STAT5 small interfering RNA (siRNA) to reduce STAT5 expression in A549 cells.
  • Employed dominant-negative (DN)-STAT5 expression via an adenoviral system to inhibit STAT5 activity.
  • Assessed EGF-induced COX-2 expression, STAT5 phosphorylation, and COX-2 promoter activity.
  • Investigated COX-2 expression in resting A549 cells to understand basal regulation.

Main Results:

  • STAT5 siRNA significantly reduced EGF-induced COX-2 expression and STAT5 phosphorylation.
  • STAT5 phosphorylation was found to be the primary mediator of EGF-induced COX-2 promoter activity.
  • Overexpression of DN-STAT5 significantly inhibited EGF-induced COX-2 expression and blocked COX-2 promoter activity.
  • EGF stimulation led to STAT5 tyrosine phosphorylation and subsequent COX-2 upregulation.
  • STAT5 siRNA inhibited COX-2 expression even in resting cells lacking detectable phosphorylated STAT5.

Conclusions:

  • Epidermal growth factor (EGF) stimulates cyclooxygenase-2 (COX-2) expression in human lung adenocarcinoma A549 cells through the activation of the STAT5 pathway.
  • STAT5 plays a critical role in mediating EGF-induced COX-2 expression and promoter activity.
  • The regulation of COX-2 expression by EGF in A549 cells may involve mechanisms independent of phosphorylated STAT5 under certain conditions (in vitro).

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.